Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Shionogi seeks Japenese nod for COVID Recombinant Protein-based Vaccine S-268019

Ruchika Sharma27 Nov 2022 1:30 PM IST

Osaka: Shionogi & Co., Ltd. has announced that it has filed for manufacturing and sales approval of S-268019, a recombinant protein-based...

Rising pollution, rising patients: Delhis Lok Nayak Hospital runs short of respiratory drugs

Switzerland experiencing medicine shortages: Pharmacists association

Ruchika Sharma27 Nov 2022 12:00 PM IST

Zurich: Switzerland is experiencing medicine shortages due to supply chain issues linked to COVID lockdowns in China and war in Europe, the country's...

Pharma and diagnostic investor Conviction Life files for IPO

Ruchika Sharma27 Nov 2022 9:00 AM IST

London: Diagnostics and pharmaceutical services technologies investor Conviction Life has filed for an initial public offering to trade on the main...

USFDA declines to approve Spectrum Pharma lung cancer drug Poziotinib

Ruchika Sharma26 Nov 2022 4:04 PM IST

Boston: Spectrum Pharmaceuticals, Inc., a biopharmaceutical company focused on novel and targeted oncology therapies, has announced that the...

India AI-powered integrated digital health gateway ekincare raises investment from MSD IDEA Studio Asia Pacific

Redcliffe Labs to invest around Rs 81 crore to expand genetic, specialised testing portfolio

Ruchika Sharma26 Nov 2022 2:00 PM IST

New Delhi: Diagnostics platform Redcliffe Labs on Friday said it plans to invest an additional USD 10 million (around Rs 81 crore) to expand its...

Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for Enhertu

Roche, Chugai Pharma to transfer Bonviva business in Japan to Taisho Pharma

Ruchika Sharma26 Nov 2022 12:51 PM IST

Tokyo: Chugai Pharmaceutical Co., Ltd., and Taisho Pharmaceutical Co., Ltd. have announced that Chugai, Taisho, and F. Hoffmann-La Roche Ltd...

DCGI gives nod to Bharat Biotech Intranasal 'Five Arms' COVID booster dose for restricted use

Ruchika Sharma26 Nov 2022 11:30 AM IST

The nasal vaccine can be taken after six months of the second dose. As this is non-invasive and needle-free, it becomes easy to administer.

Novavax claim on COVID vaccine deal breach rejected by Gavi

Ruchika Sharma25 Nov 2022 2:30 PM IST

In response to Gavi's statement, Novavax reiterated that it has been ready to meet its commitment to manufacture and deliver doses for the COVAX...

Daiichi Sankyo ENHERTU gets Japanese nod for patients with previously treated HER2 Positive Metastatic Breast Cancer

Ruchika Sharma25 Nov 2022 1:30 PM IST

ENHERTU (trastuzumab deruxtecan, fam-trastuzumab deruxtecan-nxki in the U.S. only) is a HER2 directed ADC.

Ex-Biocon team, Symbio Generrics completes capital raise from Ascent Capital

Ruchika Sharma25 Nov 2022 12:15 PM IST

The funds raised from Ascent will be utilized towards undertaking strategic acquisitions, establishing a best-in-class R&D facility, and ramping up...

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

Lupin gets 8 USFDA observations for Mandideep facility

Ruchika Sharma25 Nov 2022 11:00 AM IST

Mumbai: Lupin has recently announced that the US Food and Drug Administration (USFDA) has concluded an inspection with eight observations each...

Caplin Steriles Secures USFDA Approval for Generic Methylprednisolone Injection

FIRST: CSL bags USFDA approval for HEMGENIX to treat hemophilia B

Ruchika Sharma25 Nov 2022 11:00 AM IST

Hemophilia B is a rare, lifelong bleeding disorder caused by a single gene defect, resulting in insufficient production of factor IX, a protein...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok